Coverage
Filings
| Filing | Date |
|---|---|
| Change to the Executive Leadership Team | 21 Feb 2025 |
| Novonesis to acquire dsm-firmenich's share of the Feed Enzyme Alliance | 11 Feb 2025 |
| Trading by management and close relations of management | 3 Jan 2025 |
| Change to Novonesis' Board of Directors | 17 Dec 2024 |
| Major shareholder announcement | 29 Nov 2024 |
| Major shareholder announcement | 27 Nov 2024 |
| Major shareholder announcement | 25 Nov 2024 |
| Trading by management and close relations of management |
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 20 Nov 2024 |
| Novonesis will host an educational conference call on Energy on December 18 | 18 Nov 2024 |
| Major shareholder announcement | 13 Nov 2024 |
| Trading statement 9M 2024 | 7 Nov 2024 |
| Trading by management and close relations of management | 4 Nov 2024 |